Approach could also be applied to reversing aging and age-related diseases such as hearing loss and macular degeneration
Salk scientists have created a new version of the CRISPR/Cas9 genome editing technology that allows them to activate genes without creating breaks in the DNA, potentially circumventing a major hurdle to using gene editing technologies to treat human diseases.
“Although many studies have demonstrated that CRISPR/Cas9 can be applied as a powerful tool for gene therapy, there are growing concerns regarding unwanted mutations generated by the double-strand breaks through this technology,” says Juan Carlos Izpisua Belmonte, a professor in Salk’s Gene Expression Laboratory and senior author of the new paper, published in Cell on December 7, 2017. “We were able to get around that concern.”
In the original CRISPR/Cas9 system, the enzyme Cas9 is coupled with guide RNAs that target it to the right spot in the genome to create DSBs. Recently, some researchers have started using a “dead” form of Cas9 (dCas9), which can still target specific places in the genome, but no longer cuts DNA. Instead, dCas9 has been coupled with transcriptional activation domains—molecular switches—that turn on targeted genes. But the resulting protein—dCas9 attached to the activator switches—is too large and bulky to fit into the vehicle typically used to deliver these kinds of therapies to cells in living organisms, namely adeno-associated viruses (AAVs). The lack of an efficient delivery system makes it very difficult to use this tool in clinical applications.
Izpisua Belmonte’s team combined Cas9/dCas9 with a range of different activator switches to uncover a combination that worked even when the proteins were not fused to one another. In other words, Cas9 or dCas9 was packaged into one AAV, and the switches and guide RNAs were packaged into another. They also optimized the guide RNAs to make sure all the pieces ended up at the desired place in the genome, and that the targeted gene was strongly activated.
“The components all work together in the organism to influence endogenous genes,” says Hsin-Kai (Ken) Liao, a staff researcher in the Izpisua Belmonte lab and co–first author of the new paper. In this way, the technology operates epigenetically, meaning it influences gene activity without changing the DNA sequence.
To test the method, the researchers used mouse models of acute kidney injury, type 1 diabetes and a form of muscular dystrophy. In each case, they engineered their CRISPR/Cas9 system to boost the expression of an endogenous gene that could potentially reverse disease symptoms. In the case of kidney disease, they activated two genes known to be involved in kidney function, and observed not only increased levels of the proteins associated with those genes, but improved kidney function following an acute injury. For type 1 diabetes, they aimed to boost the activity of genes that could generate insulin-producing cells. Once again, the treatment worked, lowering blood glucose levels in a mouse model of diabetes. For muscular dystrophy, the researchers expressed genes that have been previously shown to reverse disease symptoms, including one particularly large gene that cannot easily be delivered via traditional virus-mediated gene therapies.
“We were very excited when we saw the results in mice,” adds Fumiyuki Hatanaka, a research associate in the lab and co–first author of the paper. “We can induce gene activation and at the same time see physiological changes.”
Izpisua Belmonte’s team is now working to improve the specificity of their system and to apply it to more cell types and organs to treat a wider range of human diseases, as well as to rejuvenate specific organs and to reverse the aging process and age-related conditions such as hearing loss and macular degeneration. More safety tests will be needed before human trials, they say.
The Latest on: CRISPR/Cas9 genome editing technology
- Two women won the Chemistry Nobel Prize for genome editing technologyon July 31, 2021 at 5:00 pm
Scientists Emmanuelle Charpentier and Jennifer Doudna won the 2020 Nobel Prize in Chemistry for the development of a method for genome ... gene technology's sharpest tools: The CRISPR/Cas9 genetic ...
- Microbiosci Develops Competent Services to Support B. licheniformis Genome Editingon July 29, 2021 at 5:00 pm
The B. licheniformis genome editing service provided by Creative Biogene is based on CRISPR/Cas9 technology and homologous recombination technology. Among them, CRISPR technology is derived from ...
- CRISPR/Cas9-based genome editing for autologous CAR-T cell productionon July 22, 2021 at 5:45 am
Gene editing technologies such as CRISPR/Cas9 have greater flexibility and high efficiency. CRISPR technology enables targeted insertion ... is delivery of CAR and its integration into the T cell ...
- What is Genome Editing or CRISPR Technology?on July 14, 2021 at 2:17 am
Recently WHO has released two new companion reports that give recommendations to the countries to make genome editing ... Jacques used CRISPR/ Cas9 technology which is a gene editing technology ...
- ISS researchers repaired DNA in space using CRISPR/Cas9 genome editingon July 4, 2021 at 11:52 pm
The process uses CRISPR/Cas9 genome editing technology to create precise damage in DNA strands to allow DNA repair mechanisms to be observed. The technique allows the DNA repair mechanisms to be ...
- A new study reveals unintended CRISPR/Cas9 editing eventson July 3, 2021 at 5:00 pm
In the recent decade, genome ... Xdrop technology in combination with de novo long-read sequence assembly surprisingly reveals complex genomic alterations that go along with CRISPR/Cas9 deletions.
- Astronauts carry out genome editing to study how cells repair DNAon June 30, 2021 at 11:43 am
Used on yeast cells, the technique is based CRISPR/Cas9 genome editing technology, which is used to edit animal and plant DNA with great precision. In tests on the orbiting laboratory, this tool ...
- Astronauts on board International Space Station demonstrate genome editingon June 30, 2021 at 11:06 am
The technique uses CRISPR/Cas9 genome editing technology which can be used to change the DNA of animals, plants and microorganisms with extremely high precision. The method is used to create precise ...
- Astronauts on board International Space Station demonstrate genome editingon June 30, 2021 at 11:04 am
The technique uses CRISPR/Cas9 genome editing technology which can be used to change the DNA of animals, plants and microorganisms with extremely high precision. The method is used to create ...
via Google News and Bing News